1991 - 2000 of 9134 Results
Title
Year
-
OPENTitle: Parkinson's disease drug therapies in the clinical trial pipeline: 2015–2024Journal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page: 1877718X261454154End Page: 1877718X261454154Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x261454154Best OA location URL: https://doi.org/10.1177/1877718x261454154Citation Count: 0
- Outcomes in Long‐Term Follow‐Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative2026RESTRICTEDTitle: Outcomes in Long‐Term Follow‐Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers InitiativeJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78248Citation Count: 1
-
OPENTitle: Functional Blood‐Brain Barrier Crossing by Biomimetic M13 Phage Vectors for Targeted Neuronal DeliveryJournal Name: Advanced Healthcare MaterialsPublisher: WileyVol: 15Issue #: 28Start Page: e00029End Page: e00029Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/adhm.202600029Best OA location URL: https://doi.org/10.1002/adhm.202600029Citation Count: 0
-
OPENTitle: Changes in Plasma Amyloid β 1–42 Peptide and Total Tau Protein from Normal Cognition to Sever-Stage Alzheimer’s Disease Using an Immunomagnetic Reduction AssayJournal Name: ACS OmegaPublisher: American Chemical Society (ACS)Vol: 11Issue #: 25Start Page: 36855End Page: 36865Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acsomega.6c00355Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acsomega.6c00355?ref=article_openPDFCitation Count: 0
-
OPENTitle: Fully-automated sleep staging for Parkinson’s disease and isolated REM sleep behavior disorderJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-026-02946-2Best OA location URL: https://doi.org/10.1038/s41746-026-02946-2Citation Count: 0
-
OPENTitle: Plasma proteomes of obesity and allometric body shapes in the EPIC cohortJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41598-026-64282-5Best OA location URL: https://www.nature.com/articles/s41598-026-64282-5_reference.pdfCitation Count: 0
-
OPENTitle: Integrating multi-omics summary data using a Mendelian randomization frameworkJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/bib/bbac376Best OA location URL: https://doi.org/10.1093/bib/bbac376Citation Count: 30
-
OPENTitle: Human pericytes degrade diverse α-synuclein aggregatesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 11Start Page: e0277658End Page: e0277658Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0277658Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0277658&type=printableCitation Count: 18
-
OPENTitle: Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammationJournal Name: Genome MedicinePublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 129End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13073-022-01132-9Best OA location URL: https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-022-01132-9Citation Count: 18
-
OPENTitle: Unfolded protein response IRE1 / XBP1 signaling is required for healthy mammalian brain agingJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 22Start Page: e111952End Page: e111952Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embj.2022111952Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9670206Citation Count: 77